UiPath Inc. (NYSE:PATH) Shares Sold by Bangor Savings Bank

Bangor Savings Bank reduced its stake in shares of UiPath Inc. (NYSE:PATH) by 96.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,059 shares of the healthcare company’s stock after selling 64,981 shares during the period. Bangor Savings Bank’s holdings in UiPath were worth $26,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. ORG Partners LLC boosted its holdings in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after purchasing an additional 1,112 shares during the last quarter. GAMMA Investing LLC lifted its holdings in UiPath by 40.2% in the first quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after acquiring an additional 632 shares during the last quarter. Hantz Financial Services Inc. acquired a new position in UiPath in the second quarter valued at approximately $28,000. Benjamin F. Edwards & Company Inc. lifted its holdings in UiPath by 122.5% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock valued at $58,000 after acquiring an additional 1,407 shares during the last quarter. Finally, Advisors Asset Management Inc. lifted its holdings in UiPath by 35.0% in the first quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock valued at $69,000 after acquiring an additional 787 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently commented on PATH. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a report on Friday, September 6th. BMO Capital Markets upped their price objective on UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a report on Friday, September 6th. Evercore ISI upped their price objective on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a report on Friday, September 6th. Bank of America upped their price objective on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $15.00 price objective on shares of UiPath in a report on Friday, September 6th. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, UiPath currently has an average rating of “Hold” and a consensus target price of $17.71.

UiPath Trading Down 1.0 %

UiPath stock opened at $12.17 on Wednesday. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The stock’s fifty day simple moving average is $12.18 and its 200-day simple moving average is $14.90. The firm has a market capitalization of $6.97 billion, a P/E ratio of -76.06 and a beta of 0.88.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same quarter in the prior year, the company earned ($0.09) earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Sell-side analysts predict that UiPath Inc. will post -0.23 earnings per share for the current year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the sale, the chief financial officer now owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 22.37% of the company’s stock.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.